{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:52:57Z","timestamp":1791280377985,"version":"4.1.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12011-018-1372-4","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T01:04:28Z","timestamp":1525655068000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Role of Melatonin in Aluminum-Related Neurodegenerative Disorders: a Review"],"prefix":"10.1007","volume":"188","author":[{"given":"Jos\u00e9 L.","family":"Esparza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6647-9470","authenticated-orcid":false,"given":"Jos\u00e9 L.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"key":"1372_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.tox.2008.05.004","volume":"249","author":"M G\u00f3mez","year":"2008","unstructured":"G\u00f3mez M, Esparza JL, Cabr\u00e9 M, Garc\u00eda T, Domingo JL (2008) Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer\u2019s disease. Toxicology 249:214\u2013219","journal-title":"Toxicology"},{"key":"1372_CR2","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1039\/C3EM00374D","volume":"15","author":"C Exley","year":"2013","unstructured":"Exley C (2013) Human exposure to aluminium. Environ Sci Process Impacts 15:1807\u20131816","journal-title":"Environ Sci Process Impacts"},{"key":"1372_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/JAD-121909","volume":"35","author":"JR Walton","year":"2013","unstructured":"Walton JR (2013) Aluminum involvement in the progression of Alzheimer\u2019s disease. J Alzheimers Dis 35:7\u201343 Erratum in: J Alzheimers Dis 35:875","journal-title":"J Alzheimers Dis"},{"key":"1372_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/B978-0-12-375083-9.00008-8","volume-title":"Encyclopedia of human nutrition","author":"RA Yokel","year":"2013","unstructured":"Yokel RA (2013) Aluminum. In: Caballero B (ed) Encyclopedia of human nutrition, 3rd edn. Elsevier, New York City, pp 57\u201363","edition":"3"},{"key":"1372_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1586\/14737175.2014.915745","volume":"14","author":"C Exley","year":"2014","unstructured":"Exley C (2014) What is the risk of aluminium as a neurotoxin? Expert Rev Neurother 14:589\u2013591","journal-title":"Expert Rev Neurother"},{"key":"1372_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3233\/JAD-132204","volume":"40","author":"JR Walton","year":"2014","unstructured":"Walton JR (2014) Chronic aluminum intake causes Alzheimer\u2019s disease: applying Sir Austin Bradford Hill\u2019s causality criteria. J Alzheimers Dis 40:765\u2013838","journal-title":"J Alzheimers Dis"},{"key":"1372_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1056\/NEJM197601222940402","volume":"294","author":"AC Alfrey","year":"1976","unstructured":"Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. Possible aluminium intoxication. N Engl J Med 294:184\u2013188","journal-title":"N Engl J Med"},{"key":"1372_CR8","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/jbmr.5650101219","volume":"10","author":"DA Bushinsky","year":"1995","unstructured":"Bushinsky DA, Sprague SM, Hallegot P, Girod C, Chabala JM, Levi-Setti R (1995) Effects of aluminium on bone surface ion composition. J Bone Miner Res 10:1988\u20131997","journal-title":"J Bone Miner Res"},{"key":"1372_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.morpho.2015.12.001","volume":"100","author":"D Chappard","year":"2016","unstructured":"Chappard D, Bizot P, Mabilleau G, Hubert L (2016) Aluminum and bone: review of new clinical circumstances associated with Al (3+) deposition in the calcified matrix of bone. Morphologie 100:95\u2013105","journal-title":"Morphologie"},{"key":"1372_CR10","first-page":"813","volume":"21","author":"RA Yokel","year":"2000","unstructured":"Yokel RA (2000) The toxicology of aluminum in the brain: a review. Neurotoxicology 21:813\u2013828","journal-title":"Neurotoxicology"},{"key":"1372_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2013.10.008","volume":"315","author":"SC Bondy","year":"2014","unstructured":"Bondy SC (2014) Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration. Toxicology 315:1\u20137","journal-title":"Toxicology"},{"key":"1372_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3233\/JAD-150193","volume":"47","author":"SA Virk","year":"2015","unstructured":"Virk SA, Eslick GD (2015) Aluminum levels in brain, serum, and cerebrospinal fluid are higher in Alzheimer\u2019s disease cases than in controls: a series of meta-analyses. J Alzheimers Dis 47:629\u2013638","journal-title":"J Alzheimers Dis"},{"key":"1372_CR13","first-page":"721","volume":"46","author":"A Campbell","year":"2000","unstructured":"Campbell A, Bondy SC (2000) Aluminium induced oxidative events and its relation to inflammation: a role for the metal in Alzheimer\u2019s disease. Cell Mol Biol 46:721\u2013730","journal-title":"Cell Mol Biol"},{"key":"1372_CR14","doi-asserted-by":"publisher","unstructured":"Kawahara M, Kato-Negishi M (2011) Link between aluminum and the pathogenesis of Alzheimer\u2019s disease: the integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis. https:\/\/doi.org\/10.4061\/2011\/276393","DOI":"10.4061\/2011\/276393"},{"key":"1372_CR15","first-page":"95","volume-title":"Integrative medicine","author":"K Mikhail","year":"2018","unstructured":"Mikhail K, Hwee Soo J (2018) Alzheimer disease. In: Rakel D (ed) Integrative medicine, 4th edn. Elsevier, New York City, pp 95\u2013107","edition":"4"},{"key":"1372_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1034\/j.1600-079X.2003.00048.x","volume":"35","author":"JL Esparza","year":"2003","unstructured":"Esparza JL, G\u00f3mez M, Romeu M, Mulero M, S\u00e1nchez DJ, Mallol J, Domingo JL (2003) Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin. J Pineal Res 35:32\u201339","journal-title":"J Pineal Res"},{"key":"1372_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10534-004-1201-4","volume":"17","author":"Z Rengel","year":"2004","unstructured":"Rengel Z (2004) Aluminium cycling in the soil-plant-animal-human continuum. Biometals 17:669\u2013689","journal-title":"Biometals"},{"key":"1372_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","volume":"6","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe DJ (1991) The molecular pathology of Alzheimer\u2019s disease. Neuron 6:487\u2013498","journal-title":"Neuron"},{"key":"1372_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/bpa.12059","volume":"23","author":"E Oshima","year":"2013","unstructured":"Oshima E, Ishihara T, Yokota O, Nakashima-Yasuda H, Nagao S, Ikeda C, Naohara J, Terada S, Uchitomi Y (2013) Accelerated tau aggregation, apoptosis and neurological dysfunction caused by chronic oral administration of aluminum in a mouse model of tauopathies. Brain Pathol 23:633\u2013644","journal-title":"Brain Pathol"},{"key":"1372_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H (2010) Alzheimer\u2019s disease and the \u03b2-amyloid peptide. J Alzheimers Dis 19:311\u2013323","journal-title":"J Alzheimers Dis"},{"key":"1372_CR21","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1097\/00005072-199712000-00010","volume":"56","author":"P Bozner","year":"1997","unstructured":"Bozner P, Grishko V, LeDoux SP, Wilson GL, Chyan YC, Pappolla MA (1997) The amyloid beta protein induces oxidative damage of mitochondrial DNA. J Neuropathol Exp Neurol 56:1356\u20131362","journal-title":"J Neuropathol Exp Neurol"},{"key":"1372_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1034\/j.1600-079x.2002.1819.x","volume":"32","author":"YX Shen","year":"2002","unstructured":"Shen YX, Xu SY, Wei W, Sun XX, Liu LH, Yang J, Dong C (2002) The protective effects of melatonin from oxidative damage induced by amyloid beta-peptide 25\u201335 in middle-aged rats. J Pineal Res 32:85\u201389","journal-title":"J Pineal Res"},{"key":"1372_CR23","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1074\/jbc.273.13.7185","volume":"273","author":"M Pappolla","year":"1998","unstructured":"Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M (1998) Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem 273:7185\u20137188","journal-title":"J Biol Chem"},{"key":"1372_CR24","doi-asserted-by":"publisher","first-page":"14995","DOI":"10.1021\/bi0114269","volume":"40","author":"B Poeggeler","year":"2001","unstructured":"Poeggeler B, Miravalle L, Zagorski MG, Wisniewski T, Chyan YJ, Zhang Y, Shao H, Bryant-Thomas T, Vidal R, Frangione B, Ghiso J, Pappolla MA (2001) Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. Biochemistry 40:14995\u201315001","journal-title":"Biochemistry"},{"key":"1372_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1600-079X.2009.00692.x","volume":"47","author":"JM Olcese","year":"2009","unstructured":"Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW (2009) Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 47:82\u201396","journal-title":"J Pineal Res"},{"key":"1372_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jech.50.4.401","volume":"50","author":"WF Forbes","year":"1996","unstructured":"Forbes WF, McLachlan DR (1996) Further thoughts on the aluminum-Alzheimer\u2019s disease link. J Epidemiol Community Health 50:401\u2013403","journal-title":"J Epidemiol Community Health"},{"key":"1372_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/aje\/152.1.59","volume":"152","author":"V Rondeau","year":"2000","unstructured":"Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF (2000) Relation between aluminum concentrations in drinking water and Alzheimer\u2019s disease: an 8-year follow-up study. Am J Epidemiol 152:59\u201366","journal-title":"Am J Epidemiol"},{"key":"1372_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/aje\/kwn348","volume":"169","author":"V Rondeau","year":"2009","unstructured":"Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF (2009) Aluminum and silica in drinking water and the risk of Alzheimer\u2019s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 169:489\u2013496","journal-title":"Am J Epidemiol"},{"key":"1372_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0304-3940(90)90815-Q","volume":"110","author":"J Diaz-Nido","year":"1999","unstructured":"Diaz-Nido J, Avila J (1999) Aluminum induces the in vitro aggregation of bovine brain cytoskeletal proteins. Neurosci Lett 110:221\u2013226","journal-title":"Neurosci Lett"},{"key":"1372_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408444.2014.934439","volume":"44","author":"CC Willhite","year":"2014","unstructured":"Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, Wisniewski TM, Arnold IM (2014) Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol 44:1\u201380","journal-title":"Crit Rev Toxicol"},{"key":"1372_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1471-4159.2004.02737.x","volume":"91","author":"O Wirths","year":"2004","unstructured":"Wirths O, Multhaup G, Bayer TA (2004) A modified \u03b2- amyloid hypothesis: intraneuronal accumulation of the \u03b2- amyloid peptide\u2014the first step of a fatal cascade. J Neurochem 91:513\u2013520","journal-title":"J Neurochem"},{"key":"1372_CR32","first-page":"91","volume":"799","author":"EY Yang","year":"1999","unstructured":"Yang EY, Guo-Ross SX, Bondy SC (1999) The stabilization of ferrous iron by a toxic \u03b2-amyloid fragment and by an aluminum salt. Brain Res 799:91\u201396","journal-title":"Brain Res"},{"key":"1372_CR33","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1097\/00001756-199710200-00043","volume":"8","author":"C Exley","year":"1997","unstructured":"Exley C (1997) ATP-promoted amyloidosis of an amyloid \u03b2-peptide. Neuroreport 8:3411\u20133414","journal-title":"Neuroreport"},{"key":"1372_CR34","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1096\/fj.02-0012fje","volume":"16","author":"D Pratico","year":"2002","unstructured":"Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM (2002) Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 16:1138\u20131140","journal-title":"FASEB J"},{"key":"1372_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/0046-8177(95)90001-2","volume":"26","author":"RE Mrak","year":"1995","unstructured":"Mrak RE, Sheng JG, Griffin WS (1995) Glial cytokines in Alzheimer\u2019s disease: review and pathogenic implications. Hum Pathol 26:816\u2013823","journal-title":"Hum Pathol"},{"key":"1372_CR36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/(SICI)1096-9861(19980713)396:4<511::AID-CNE7>3.0.CO;2-4","volume":"396","author":"SD Styren","year":"1998","unstructured":"Styren SD, Kamboh MI, DeKosky ST (1998) Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer\u2019s disease. J Comp Neurol 396:511\u2013520","journal-title":"J Comp Neurol"},{"key":"1372_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1749-6632.1991.tb00204.x","volume":"640","author":"K Beyreuther","year":"1991","unstructured":"Beyreuther K, Bush AI, Dyrks T, Hilbich C, K\u00f6nig G, M\u00f6nning U, Multhaup G, Prior R, Rumble B, Schubert W (1991) Mechanisms of amyloid deposition in Alzheimer\u2019s disease. Ann N Y Acad Sci 640:129\u2013139","journal-title":"Ann N Y Acad Sci"},{"key":"1372_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"1372_CR39","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.freeradbiomed.2004.09.010","volume":"37","author":"SS Leonard","year":"2004","unstructured":"Leonard SS, Harris GK, Shi X (2004) Metal-induced oxidative stress and signal transduction. Free Radic Biol Med 37:1921\u20131942","journal-title":"Free Radic Biol Med"},{"key":"1372_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00001756-199801260-00001","volume":"9","author":"GF Landeghem van","year":"1998","unstructured":"van Landeghem GF, Sikstrom C, Beckman LE, Adolfsson R, Beckman L (1998) Transferrin C2, metal binding and Alzheimer\u2019s disease. Neuroreport 9:177\u2013179","journal-title":"Neuroreport"},{"key":"1372_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0361-9230(01)00475-0","volume":"55","author":"M Kawahara","year":"2001","unstructured":"Kawahara M, Midori K, Kuroda Y (2001) Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of \u03b2-amyloid protein. Brain Res Bull 55:211\u2013217","journal-title":"Brain Res Bull"},{"key":"1372_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/0-387-23226-5_11","volume":"38","author":"C Exley","year":"2005","unstructured":"Exley C (2005) The aluminium-amyloid cascade hypothesis and Alzheimer\u2019s disease. Subcell Biochem 38:225\u2013234","journal-title":"Subcell Biochem"},{"key":"1372_CR43","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s11011-017-0077-2","volume":"32","author":"G Morris","year":"2017","unstructured":"Morris G, Puri BK, Frye RE (2017) The putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved? Metab Brain Dis 32:1335\u20131355","journal-title":"Metab Brain Dis"},{"key":"1372_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2004.10.009","volume":"38","author":"M G\u00f3mez","year":"2005","unstructured":"G\u00f3mez M, Esparza JL, Noqu\u00e9s MR, Giralt M, Cabr\u00e9 M, Domingo JL (2005) Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic Biol Med 38:104\u2013111","journal-title":"Free Radic Biol Med"},{"key":"1372_CR45","first-page":"161","volume":"3","author":"M Chakrabarty","year":"2012","unstructured":"Chakrabarty M, Bhat P, Kumari S, D\u2019Souza A, Bairy KL, Chaturvedi A (2012) Cortico-hippocampal salvage in chronic aluminum induced neurodegeneration by Celastrus paniculatus seed oil: Neurobehavioural, biochemical, histological study. J Pharmacol Pharmacother 3:161\u2013171","journal-title":"J Pharmacol Pharmacother"},{"key":"1372_CR46","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","volume":"15","author":"M Manczak","year":"2006","unstructured":"Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of Abeta accumulation in Alzheimer\u2019s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15:1437\u20131449","journal-title":"Hum Mol Genet"},{"key":"1372_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","volume":"14","author":"PH Reddy","year":"2008","unstructured":"Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer\u2019s disease. Trends Mol Med 14:45\u201353","journal-title":"Trends Mol Med"},{"key":"1372_CR48","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","volume":"20","author":"MJ Calkins","year":"2011","unstructured":"Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 20:4515\u20134529","journal-title":"Hum Mol Genet"},{"key":"1372_CR49","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, Tyagi N (2016) Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies. Mol Neurobiol 53:648\u2013661","journal-title":"Mol Neurobiol"},{"key":"1372_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152708783885156","volume":"7","author":"PI Moreira","year":"2008","unstructured":"Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G (2008) Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 7:3\u201310","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1372_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1423-0127-19-51","volume":"19","author":"CY Yuan","year":"2012","unstructured":"Yuan CY, Lee YJ, Hsu GS (2012) Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats. J Biomed Sci 19:51","journal-title":"J Biomed Sci"},{"key":"1372_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-079X.1995.tb00171.x","volume":"19","author":"D Acu\u00f1a-Castroviejo","year":"1995","unstructured":"Acu\u00f1a-Castroviejo D, Escames G, Mac\u00edas M, Mu\u00f1oz Hoyos A, Molina Carballo A, Arauzo M, Montes R (1995) Cell protective role of melatonin in the brain. J Pineal Res 19:57\u201363","journal-title":"J Pineal Res"},{"key":"1372_CR53","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0891-5849(00)00435-4","volume":"29","author":"DX Tan","year":"2000","unstructured":"Tan DX, Manchester LC, Reiter RJ, Plummer BF, Limson J, Weintraub ST, Qi W (2000) Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 29:1177\u20131185","journal-title":"Free Radic Biol Med"},{"key":"1372_CR54","doi-asserted-by":"publisher","first-page":"21937","DOI":"10.1074\/jbc.274.31.21937","volume":"274","author":"YJ Chyan","year":"1999","unstructured":"Chyan YJ, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, Pappolla MA (1999) Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem 274:21937\u201321942","journal-title":"J Biol Chem"},{"key":"1372_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-079X.1995.tb00133.x","volume":"18","author":"RJ Reiter","year":"1995","unstructured":"Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acu\u00f1a-Castroviejo D (1995) A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 18:1\u201311","journal-title":"J Pineal Res"},{"key":"1372_CR56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1749-6632.2001.tb03627.x","volume":"939","author":"J Reiter","year":"2001","unstructured":"Reiter J, Acuna-Castroviejo D, Tan DX, Burkhardt S (2001) Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci 939:200\u2013215","journal-title":"Ann N Y Acad Sci"},{"key":"1372_CR57","first-page":"11","volume":"52","author":"RJ Reiter","year":"2007","unstructured":"Reiter RJ, Tan DX, Manchester LC, Pilar Terron M, Flores LJ, Koppisepi S (2007) Medical implications of melatonin: receptor mediated and receptor independent actions. Adv Med Sci 52:11\u201328","journal-title":"Adv Med Sci"},{"key":"1372_CR58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1749-6632.1994.tb21831.x","volume":"738","author":"B Poeggeler","year":"1994","unstructured":"Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LR (1994) Melatonina highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann N Y Acad Sci 738:419\u2013420","journal-title":"Ann N Y Acad Sci"},{"key":"1372_CR59","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1210\/endo.138.2.4925","volume":"138","author":"AJ McArthur","year":"1997","unstructured":"McArthur AJ, Hunt AE, Gillette MU (1997) Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 138:627\u2013634","journal-title":"Endocrinology"},{"key":"1372_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-079X.2004.00196.x","volume":"38","author":"YH Wu","year":"2005","unstructured":"Wu YH, Swaab DF (2005) The human pineal gland and melatonin in aging and Alzheimer\u2019s disease. J Pineal Res 38:145\u2013152","journal-title":"J Pineal Res"},{"key":"1372_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","volume":"61","author":"B Claustrat","year":"2015","unstructured":"Claustrat B, Leston J (2015) Melatonin: physiological effects in humans. Neurochirurgie 61:77\u201384","journal-title":"Neurochirurgie"},{"key":"1372_CR62","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1073\/pnas.91.5.1824","volume":"91","author":"AB Dollins","year":"1994","unstructured":"Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH (1994) Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A 91:1824\u20131182","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1372_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1568026023394335","volume":"2","author":"JM Guerrero","year":"2002","unstructured":"Guerrero JM, Reiter RJ (2002) Melatonin-immune system relationships. Curr Top Med Chem 2:167\u2013179","journal-title":"Curr Top Med Chem"},{"key":"1372_CR64","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/157015910792246155","volume":"8","author":"E Esposito","year":"2010","unstructured":"Esposito E, Cuzzocrea S (2010) Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 8:228\u2013242","journal-title":"Curr Neuropharmacol"},{"key":"1372_CR65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1600-079X.2005.00248.x","volume":"39","author":"C Tomas-Zapico","year":"2005","unstructured":"Tomas-Zapico C, Coto-Montes A (2005) A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 39:99\u2013104","journal-title":"J Pineal Res"},{"key":"1372_CR66","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","volume":"112","author":"CX Gong","year":"2005","unstructured":"Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2005) Post-translational modifications of tau protein in Alzheimer\u2019s disease. J Neural Transm 112:813\u2013838","journal-title":"J Neural Transm"},{"key":"1372_CR67","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11064-007-9563-y","volume":"33","author":"XC Wang","year":"2008","unstructured":"Wang XC, Zhang YC, Chatterjie N, Grundke-Iqbal I, Iqbal K, Wang JZ (2008) Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells. Neurochem Res 33:1138\u20131144","journal-title":"Neurochem Res"},{"key":"1372_CR68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0188-4409(01)00268-5","volume":"32","author":"G Letechipia-Vallejo","year":"2001","unstructured":"Letechipia-Vallejo G, Gonzalez-Burgos I, Cervantes M (2001) Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats. Arch Med Res 32:186\u2013192","journal-title":"Arch Med Res"},{"key":"1372_CR69","first-page":"329","volume":"37","author":"J Zhang","year":"2002","unstructured":"Zhang J, Guo JD, Xing SH, Gu SL, Dai TJ (2002) The protective effects of melatonin on global cerebral ischemia-reperfusion injury in gerbils. Yao Xue Xue Bao 37:329\u2013333 [Article in Chinese]","journal-title":"Yao Xue Xue Bao"},{"key":"1372_CR70","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/0019-5359.28983","volume":"60","author":"T Ravindra","year":"2006","unstructured":"Ravindra T, Lakshmi NK, Ahuja YR (2006) Melatonin in pathogenesis and therapy of cancer. Indian J Med Sci 60:523\u2013535","journal-title":"Indian J Med Sci"},{"key":"1372_CR71","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.fct.2014.05.025","volume":"70","author":"C Paolo Di","year":"2014","unstructured":"Di Paolo C, Cabr\u00e9 M, Domingo JL, G\u00f3mez M (2014) Melatonin does not modify the concentration of different metals in A\u03b2PP transgenic mice. Food Chem Toxicol 70:252\u2013259","journal-title":"Food Chem Toxicol"},{"key":"1372_CR72","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1600-079X.2005.00308.x","volume":"40","author":"D Alvira","year":"2006","unstructured":"Alvira D, Tajes M, Verdaguer E, Acu\u00f1a-Castroviejo D, Folch J, Camins A, Pallas M (2006) Inhibition of the cdk5\/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease. J Pineal Res 40:251\u2013258","journal-title":"J Pineal Res"},{"key":"1372_CR73","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1600-079X.2006.00395.x","volume":"42","author":"G Letechip\u00eda-Vallejo","year":"2007","unstructured":"Letechip\u00eda-Vallejo G, L\u00f3pez-Loeza E, Espinoza-Gonz\u00e1lez V, Gonz\u00e1lez-Burgos I, Olvera-Cort\u00e9s ME, Moral\u00ed G, Cervantes M (2007) Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats. J Pineal Res 42:138\u2013146","journal-title":"J Pineal Res"},{"key":"1372_CR74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","volume":"42","author":"KS Saravanan","year":"2007","unstructured":"Saravanan KS, Sindhu KM, Mohanakumar KP (2007) Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J Pineal Res 42:247\u2013253","journal-title":"J Pineal Res"},{"key":"1372_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1600-079X.2007.00469.x","volume":"43","author":"R Sharma","year":"2007","unstructured":"Sharma R, McMillan CR, Niles LP (2007) Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease. J Pineal Res 43:245\u2013254","journal-title":"J Pineal Res"},{"key":"1372_CR76","first-page":"287","volume-title":"Pharmacology of cerebral ischemia","author":"RJ Reiter","year":"1994","unstructured":"Reiter RJ (1994) The neuroimmune melatonin: its role in antioxidant protection with special reference to the brain. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia. Medpharm Scientific Publishers, Stuttgart, pp 287\u2013296"},{"key":"1372_CR77","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1600-079X.2007.00534.x","volume":"44","author":"S Samantaray","year":"2008","unstructured":"Samantaray S, Sribnick EA, Das A, Knaryan VH, Matzelle DD, Yallapragada AV, Reiter RJ, Ray SK, Banik NL (2008) Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res 44:348\u2013357","journal-title":"J Pineal Res"},{"key":"1372_CR78","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12011-015-0320-9","volume":"168","author":"O Karabulut-Bulan","year":"2015","unstructured":"Karabulut-Bulan O, Bayrak BB, Arda-Pirincci P, Sarikaya-Unal G, Us H, Yanardag R (2015) Role of exogenous melatonin on cell proliferation and oxidant\/antioxidant system in aluminum-induced renal toxicity. Biol Trace Elem Res 168:141\u2013149","journal-title":"Biol Trace Elem Res"},{"key":"1372_CR79","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0006-2952(97)00062-2","volume":"54","author":"G Multhaup","year":"1997","unstructured":"Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Beher D, Masters CL, Beyreuther K (1997) Reactive oxygen species and Alzheimer\u2019s disease. Biochem Pharmacol 54:533\u2013539","journal-title":"Biochem Pharmacol"},{"key":"1372_CR80","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1586\/14737175.2015.1058160","volume":"15","author":"C Carvalho","year":"2015","unstructured":"Carvalho C, Correia SC, Cardoso S, Pl\u00e1cido AI, Candeias E, Duarte AI, Moreira PI (2015) The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases. Expert Rev Neurother 15:867\u2013884","journal-title":"Expert Rev Neurother"},{"key":"1372_CR81","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795","journal-title":"Nature"},{"key":"1372_CR82","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2174\/1568026615666150220120946","volume":"15","author":"C Karaaslan","year":"2015","unstructured":"Karaaslan C, Suzen S (2015) Antioxidant properties of melatonin and its potential action in diseases. Curr Top Med Chem 15:894\u2013903","journal-title":"Curr Top Med Chem"},{"key":"1372_CR83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00002093-199803001-00005","volume":"12","author":"R Mielke","year":"1998","unstructured":"Mielke R, Moller HJ, Erkinjuntti T, Rosenkranz B, Rother M, Kittner B (1998) Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. Alzheimer Dis Assoc Disord 12:29\u201335","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1372_CR84","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF02255928","volume":"5","author":"AY Sun","year":"1998","unstructured":"Sun AY, Chen YM (1998) Oxidative stress and neurodegenerative disorders. J Biomed Sci 5:401\u2013414","journal-title":"J Biomed Sci"},{"key":"1372_CR85","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/JAD-132738","volume":"42","author":"E Radi","year":"2014","unstructured":"Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 42:125\u2013152","journal-title":"J Alzheimers Dis"},{"key":"1372_CR86","doi-asserted-by":"publisher","unstructured":"Alavi Naini SM, Soussi-Yanicostas N (2015) Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies? Ox Med Cell Long. https:\/\/doi.org\/10.1155\/2015\/151979","DOI":"10.1155\/2015\/151979"},{"key":"1372_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2012.12.026","volume":"242","author":"X Tian","year":"2013","unstructured":"Tian X, Zhang L, Wang J, Dai J, Shen S, Yang L, Huang P (2013) The protective effect of hyperbaric oxygen and Ginkgo biloba extract on A\u03b225-35-induced oxidative stress and neuronal apoptosis in rats. Behav Brain Res 242:1\u20138","journal-title":"Behav Brain Res"},{"key":"1372_CR88","first-page":"4","volume":"18","author":"N Farina","year":"2017","unstructured":"Farina N, Llewellyn D, Isaac MGEKN, Tabet N (2017) Vitamin E for Alzheimer\u2019s dementia and mild cognitive impairment. Cochrane Database Syst Rev 18:4","journal-title":"Cochrane Database Syst Rev"},{"key":"1372_CR89","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1034\/j.1600-079X.2003.00065.x","volume":"35","author":"JN Zhou","year":"2003","unstructured":"Zhou JN, Liu RY, Kamphorst W, Hofman MA, Swaab DF (2003) Early neuropathological Alzheimer\u2019s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 35:125\u2013130","journal-title":"J Pineal Res"},{"key":"1372_CR90","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.phrs.2012.01.003","volume":"65","author":"A Carpentieri","year":"2012","unstructured":"Carpentieri A, D\u00edaz de Barboza G, Areco V, Peralta L\u00f3pez M, Tolosa de Talamoni N (2012) New perspectives in melatonin uses. Pharmacol Res 65:437\u2013444","journal-title":"Pharmacol Res"},{"key":"1372_CR91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1034\/j.1600-079X.2000.290102.x","volume":"29","author":"G Benitez-King","year":"2000","unstructured":"Benitez-King G (2000) PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells. J Pineal Res 29:8\u201314","journal-title":"J Pineal Res"},{"key":"1372_CR92","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0014-4886(03)00085-2","volume":"182","author":"G Benitez-King","year":"2003","unstructured":"Benitez-King G, T\u00fanez I, Bellon A, Ort\u00edz GG, Ant\u00f3n-Tay F (2003) Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells. Exp Neurol 182:151\u2013159","journal-title":"Exp Neurol"},{"key":"1372_CR93","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fct.2014.03.043","volume":"70","author":"MS Allagui","year":"2014","unstructured":"Allagui MS, Feriani A, Saoudi M, Badraoui R, Bouoni Z, Nciri R, Murat JC, Elfeki A (2014) Effects of melatonin on aluminium-induced neurobehavioral and neurochemical changes in aging rats. Food Chem Toxicol 70:84\u201393","journal-title":"Food Chem Toxicol"},{"key":"1372_CR94","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/iep.12122","volume":"96","author":"EM Al-Olayan","year":"2015","unstructured":"Al-Olayan EM, El-Khadragy MF, Abdel Moneim AE (2015) The protective properties of melatonin against aluminium-induced neuronal injury. Int J Exp Pathol 96:196\u2013202","journal-title":"Int J Exp Pathol"},{"key":"1372_CR95","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12011-009-8490-y","volume":"135","author":"T Garc\u00eda","year":"2010","unstructured":"Garc\u00eda T, Esparza JL, Giralt M, Romeu M, Domingo JL, G\u00f3mez M (2010) Protective role of melatonin on oxidative stress status and RNA expression in cerebral cortex and cerebellum of AbetaPP transgenic mice after chronic exposure to aluminum. Biol Trace Elem Res 135:220\u2013232","journal-title":"Biol Trace Elem Res"},{"key":"1372_CR96","first-page":"609","volume":"26","author":"SK Abd-Elghaffar","year":"2005","unstructured":"Abd-Elghaffar SK, El-Sokkary GH, Sharkawy AA (2005) Aluminum-induced neurotoxicity and oxidative damage in rabbits: protective effect of melatonin. Neuro Endocrinol Lett 26:609\u2013616","journal-title":"Neuro Endocrinol Lett"},{"key":"1372_CR97","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1600-079X.1998.tb00370.x","volume":"24","author":"WM Daniels","year":"1998","unstructured":"Daniels WM, van Rensburg SJ, van Zyl JM, Taljaard JJ (1998) Melatonin prevents beta-amyloid-induced lipid peroxidation. J Pineal Res 24:78\u201382","journal-title":"J Pineal Res"},{"key":"1372_CR98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jtemb.2007.04.002","volume":"21","author":"CD Albendea","year":"2007","unstructured":"Albendea CD, G\u00f3mez-Trull\u00e9n EM, Fuentes-Broto L, Miana-Mena FJ, Mill\u00e1n-Plano S, Reyes-Gonzales MC, Mart\u00ednez-Ballar\u00edn E, Garc\u00eda JJ (2007) Melatonin reduces lipid and protein oxidative damage in synaptosomes due to aluminium. J Trace Elem Med Biol 21:261\u2013268","journal-title":"J Trace Elem Med Biol"},{"key":"1372_CR99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-079X.2005.00225.x","volume":"39","author":"JL Esparza","year":"2005","unstructured":"Esparza JL, G\u00f3mez M, Nogu\u00e9s MR, Paternain JL, Mallol J, Domingo JL (2005) Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J Pineal Res 39:129\u2013136","journal-title":"J Pineal Res"},{"key":"1372_CR100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/hipo.20612","volume":"20","author":"T Garc\u00eda","year":"2010","unstructured":"Garc\u00eda T, Esparza JL, Nogu\u00e9s MR, Romeu M, Domingo JL, G\u00f3mez M (2010) Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer\u2019s disease after chronic exposure to aluminum. Hippocampus 20:218\u2013225","journal-title":"Hippocampus"},{"key":"1372_CR101","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tox.2009.09.009","volume":"265","author":"T Garc\u00eda","year":"2009","unstructured":"Garc\u00eda T, Ribes D, Colomina MT, Cabr\u00e9 M, Domingo JL, G\u00f3mez M (2009) Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer\u2019s disease. Toxicology 265:49\u201355","journal-title":"Toxicology"},{"key":"1372_CR102","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.fct.2014.04.022","volume":"69","author":"C Paolo Di","year":"2014","unstructured":"Di Paolo C, Reverte I, Colomina MT, Domingo JL, G\u00f3mez M (2014) Chronic exposure to aluminum and melatonin through the diet: neurobehavioral effects in a transgenic mouse model of Alzheimer disease. Food Chem Toxicol 69:320\u2013329","journal-title":"Food Chem Toxicol"},{"key":"1372_CR103","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jinorgbio.2009.07.023","volume":"103","author":"S Yumoto","year":"2009","unstructured":"Yumoto S, Kakimi S, Ohsaki A, Ishikawa A (2009) Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J Inorg Biochem 103:1579\u20131584","journal-title":"J Inorg Biochem"},{"key":"1372_CR104","first-page":"415","volume":"34","author":"MS Allagui","year":"2018","unstructured":"Allagui MS, Hachani R, Saidi S, Feriani A, Murat JC, Kacem K, El Feki A (2018) Pleiotropic protective roles of melatonin against aluminium-induced toxicity in rats. Gen Physiol Biophys 34:415\u2013424","journal-title":"Gen Physiol Biophys"},{"key":"1372_CR105","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1525-1373.2000.22356.x","volume":"223","author":"A Campbell","year":"2000","unstructured":"Campbell A, Kumar A, La Rosa FG, Prasad KN, Bondy SC (2000) Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells. Proc Soc Exp Biol Med 223:397\u2013402","journal-title":"Proc Soc Exp Biol Med"},{"key":"1372_CR106","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0891-5849(98)00308-6","volume":"26","author":"A Campbell","year":"1999","unstructured":"Campbell A, Prasad KN, Bondy SC (1999) Aluminum-induced oxidative events in cell lines: glioma are more responsive than neuroblastoma. Free Radic Biol Med 26:1166\u20131171","journal-title":"Free Radic Biol Med"},{"key":"1372_CR107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/alzrt150","volume":"4","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ (2012) NF-kappaB-regulated, proinflammatory miRNAs in Alzheimer\u2019s disease. Alzheimers Res Ther 4:47","journal-title":"Alzheimers Res Ther"},{"key":"1372_CR108","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","volume":"58","author":"J Emerit","year":"2004","unstructured":"Emerit J, Edeas M, Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58:39\u201346","journal-title":"Biomed Pharmacother"},{"key":"1372_CR109","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.neurobiolaging.2015.05.010","volume":"36","author":"C Janus","year":"2015","unstructured":"Janus C, Flores AY, Xu G, Borchelt DR (2015) Behavioral abnormalities in APPSwe\/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains. Neurobiol Aging 36:2519\u20132532","journal-title":"Neurobiol Aging"},{"key":"1372_CR110","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1034\/j.1600-079X.2003.00057.x","volume":"35","author":"S Rosales-Corral","year":"2003","unstructured":"Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Velazquez M, Martinez-Barboza G, Acosta-Martinez JP, Ortiz GG (2003) Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res 35:80\u201384","journal-title":"J Pineal Res"},{"key":"1372_CR111","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1749-6632.1999.tb08028.x","volume":"890","author":"RJ Reiter","year":"1999","unstructured":"Reiter RJ, Cabrera J, Sainz RM, Mayo JC, Manchester LC, Tan DX (1999) Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington\u2019s disease, Alzheimer\u2019s disease and parkinsonism. Ann N Y Acad Sci 890:471\u2013485","journal-title":"Ann N Y Acad Sci"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-018-1372-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-018-1372-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-018-1372-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:11:19Z","timestamp":1720278679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-018-1372-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s12011-018-1372-4","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,7]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}